Related Experiment Video
Updated: Jul 26, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
The RNA-Binding Proteins OAS1, ZFP36L2, and DHX58 Are Involved in the Regulation of CD44 mRNA Splicing in Colorectal
V O Novosad1,2, D V Maltseva3,4
1Faculty of Biology and Biotechnologies, National Research University Higher School of Economics (HSE University), Moscow, Russia.
Abstract:
Regulation of alternative splicing is carried out by RNA-binding proteins. Each alternative splicing event is controlled by several RNA-binding proteins, which in combination create the distribution of alternative splicing products in a given cell type. Transmembrane protein CD44 plays an important role at various stages of the metastatic cascade and is considered as a promising molecule for the therapy of tumor diseases and the construction of prognostic classifiers. However, the functions of specific isoforms of this protein may differ significantly. In this work, we performed a bioinformatic search of RNA-binding proteins that can determine the expression of clinically significant isoforms 3 and 4 of CD44 protein. The analysis revealed five RNA-binding proteins, three of which (OAS1, ZFP36L2, and DHX58) are shown for the first time as potential regulators of the studied process.
Insights
This study identifies novel RNA-binding proteins regulating CD44 protein isoforms crucial for cancer. OAS1, ZFP36L2, and DHX58 are newly found regulators of CD44 isoforms 3 and 4.
Area of Science:
- Molecular Biology
- Bioinformatics
- Cancer Research
Background:
- Alternative splicing is regulated by RNA-binding proteins, influencing cellular functions.
- Transmembrane protein CD44 is vital in cancer metastasis and a target for therapies and prognostic markers.
- Specific CD44 isoforms have distinct functions, necessitating targeted study.
Purpose of the Study:
- To identify RNA-binding proteins that regulate clinically significant CD44 protein isoforms 3 and 4.
- To explore novel regulators of CD44 alternative splicing.
Main Methods:
- Bioinformatic analysis was employed to search for RNA-binding proteins.
- The study focused on identifying regulators of CD44 isoforms 3 and 4.
Main Results:
- Five RNA-binding proteins were identified as potential regulators of CD44 isoforms 3 and 4.
- OAS1, ZFP36L2, and DHX58 were identified as novel regulators in this context.
Conclusions:
- The findings reveal new regulatory mechanisms for CD44 alternative splicing.
- OAS1, ZFP36L2, and DHX58 represent potential therapeutic targets or biomarkers in cancer.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Regulation of Expression at Multiple Steps
Regulated mRNA Transport
lncRNA - Long Non-coding RNAs

